Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer Cells (Q90102543)

From Wikidata

Jump to navigation Jump to search

scientific article published on 13 September 2019

Language	Label	Description	Also known as
English	Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer Cells	scientific article published on 13 September 2019

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31520223%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer Cells (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31520223%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

triple-negative breast cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31520223%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

author name string

Di Wu

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31520223%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Yao Chen

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31520223%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Shun Wen

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31520223%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Yi Wen

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31520223%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Rong Wang

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31520223%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Qiuting Zhang

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31520223%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Ge Qin

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31520223%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Huimei Yi

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31520223%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Mi Wu

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31520223%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Lu Lu

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31520223%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Xiyun Deng

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31520223%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

publication date

13 September 2019

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31520223%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Nanoscale Research Letters

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31520223%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

14

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31520223%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31520223%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

314

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31520223%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Potentiated antitumour effects of cisplatin and lovastatin against MmB16 melanoma in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction of cytosine arabinoside and lovastatin in human leukemia cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HMG-CoA reductase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast cancer growth prevention by statins

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic drug combinations tend to improve therapeutically relevant selectivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor delivery of macromolecular drugs based on the EPR effect

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combinatorial drug conjugation enables nanoparticle dual-drug delivery.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential interactions between statins and P-glycoprotein: implications for exploiting statins as anticancer agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Revisiting the isobole and related quantitative methods for assessing drug synergism

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative methods for assessing drug synergism

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

pH-sensitive nano-systems for drug delivery in cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Co-delivery of cisplatin and rapamycin for enhanced anticancer therapy through synergistic effects and microenvironment modulation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis and Self-Assembly of a Mikto-Arm Star Dual Drug Amphiphile Containing both Paclitaxel and Camptothecin

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of an Adjuvant Chemotherapy Regimen for Early-Stage Breast Cancer: A Systematic Review and Network Meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of Lovastatin on MDA-MB-231 Breast Cancer Cells: An Antibody Microarray Analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rhinacanthin-C enhances doxorubicin cytotoxicity via inhibiting the functions of P-glycoprotein and MRP2 in breast cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic chemotherapeutic effect of sorafenib-loaded pullulan-Dox conjugate nanoparticles against murine breast carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholesterol-Modified Amino-Pullulan Nanoparticles as a Drug Carrier: Comparative Study of Cholesterol-Modified Carboxyethyl Pullulan and Pullulan Nanoparticles

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of Particle Hydrophobicity, Surface Charge, Media pH Value and Complexation with Human Serum Albumin on Drug Release Behavior of Mitoxantrone-Loaded Pullulan Nanoparticles

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methotrexate-Camptothecin Prodrug Nanoassemblies as a Versatile Nanoplatform for Biomodal Imaging-Guided Self-Active Targeted and Synergistic Chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nano-sized solid dispersions based on hydrophobic-hydrophilic conjugates for dissolution enhancement of poorly water-soluble drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quaking Inhibits Doxorubicin-Mediated Cardiotoxicity Through Regulation of Cardiac Circular RNA Expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cerasomal Lovastatin Nanohybrids for Efficient Inhibition of Triple-Negative Breast Cancer Stem Cells To Improve Therapeutic Efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Investigation of different types of nano drug delivery systems of atorvastatin for the treatment of hyperlipidemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loading Lovastatin into Camptothecin-Floxuridine Conjugate Nanocapsules for Enhancing Anti-metastatic Efficacy of Cocktail Chemotherapy on Triple-negative Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amphiphilic Drug Conjugates as Nanomedicines for Combined Cancer Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In the triple-negative breast cancer MDA-MB-231 cell line, sulforaphane enhances the intracellular accumulation and anticancer action of doxorubicin encapsulated in liposomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ratiometric co-encapsulation and co-delivery of doxorubicin and paclitaxel by tumor-targeted lipodisks for combination therapy of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31520223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S11671-019-3146-0

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31520223%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31520223%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31520223%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q90102543&oldid=1541703740"